TCR2 Therapeutics Inc.
COMPOSITIONS AND METHODS FOR TCR REPROGRAMMING USING FUSION PROTEINS
Last updated:
Abstract:
Provided herein are T cell receptor (TCR) fusion proteins (TFPs) having specificity for more than one tumor cell associated antigen, T cells engineered to express one or more TFP, and methods of use thereof for the treatment of diseases, including cancer.
Status:
Application
Type:
Utility
Filling date:
30 Aug 2019
Issue date:
19 Aug 2021